Phase 3b/4 head-to-head SELECT-SWITCH study tested Humira vs Rinvoq in 492 RA MTX pts failing a TNFi… Read More
2025
Starting Nov. 13, the long-running ACR@Work newsletter is transforming into The Rheum Advocate, delivering the latest updates… Read More
The ACR’s resolutions at the Interim HOD meeting, held Nov. 14–18, will address non-compete agreements as well… Read More
Study from Czech ATTRA registry of 8,543 RA pts 641 (7.5%) met criteria for D2T-RA & 1,825… Read More
Colchicine Ineffective in Long COVID jjcush@gmail.com Tue, 10/21/2025 – 14:20 Read More
Conditions: Interstitial Lung Disease Due to Systemic Disease (Disorder); Interstitial Lung Disease in Patients With Rheumatoid Arthritis;… Read More
Conditions: Systemic Lupus Erythematosus; Idiopahic Inflammatory Myopathies; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Sjögren’s Syndrome; Antiphospholipid Syndrome; Immune Thrombocytopenia;… Read More
Conditions: Interstitial Lung Disease Due to Systemic Disease (Disorder); Interstitial Lung Disease in Patients With Rheumatoid Arthritis;… Read More
Conditions: Arthritis, Rheumatoid Interventions: Drug: Tulisokibart; Drug: Placebo; Drug: Methotrexate Sponsors: Merck Sharp & Dohme LLC Recruiting Read More
Conditions: Systemic Lupus Erythematosus; Idiopahic Inflammatory Myopathies; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Sjögren’s Syndrome; Antiphospholipid Syndrome; Immune Thrombocytopenia;… Read More
Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Axial Spondyloarthritis; Rheumatic Diseases; Rheumatic Joint Disease; PsA (Psoriatic Arthritis); AxSpA; Rheumatologic… Read More
Conditions: Arthritis, Rheumatoid Interventions: Drug: Tulisokibart; Drug: Placebo; Drug: Methotrexate Sponsors: Merck Sharp & Dohme LLC Recruiting Read More
Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Axial Spondyloarthritis; Rheumatic Diseases; Rheumatic Joint Disease; PsA (Psoriatic Arthritis); AxSpA; Rheumatologic… Read More
Conditions: Rheumatoid Arthritis Interventions: Drug: Afimkibart; Drug: Placebo Sponsors: Hoffmann-La Roche Not yet recruiting Read More
Conditions: Refractory Autoimmune Diseases Interventions: Genetic: BMS-986515; Drug: Fludarabine; Drug: Cyclophosphamide; Drug: Tocilizumab Sponsors: Juno Therapeutics, Inc.,… Read More
Conditions: Refractory Rheumatoid Arthritis (RA); Idiopathic Inflammatory Myopathies (IIMs); Systemic Sclerosis (SSc); Rheumatoid Arthritis (RA; IIM; Myositis;… Read More
Conditions: Rheumatoid Arthritis Interventions: Drug: GS-0151; Drug: Placebo Sponsors: Gilead Sciences Recruiting Read More
Conditions: Rheumatoid Arthritis Interventions: Drug: LY3541860 Sponsors: Eli Lilly and Company Recruiting Read More
Conditions: Rheumatoid Arthritis Interventions: Drug: IMVT-1402; Drug: Placebo Sponsors: Immunovant Sciences GmbH Recruiting Read More
Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2025 American College of Rheumatology (ACR) Convergence. GlobeNewswire… Read More
30% of RA pts have non-alcoholic fatty liver disease (NAFLD). In 170 pts on MTX or biologics… Read More
… Rheumatology, to demonstrate how its unique impact across the full research continuum is shaping the next… Read More
Request PDF | Dual evaluation of Citrulluscolocynthis fruit extract for anti-rheumatic activity: integrating in silico docking and… Read More
Meritus Health is pleased to welcome Mary R. Romanic, M.D., to Meritus Rheumatology. She is now seeing… Read More
Bad Actor Cofactor (10.17.2025) Dr. Jack Cush reviews the news and journal reports, discusses pediatric reports, pregn… Read More